Senior Director, Brand Lead, IBSRELA

Waltham, MA (On-site)

$266K/yr – $325K/yrSenior Level10+ years expFull time

Posted 6 hrs ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and lead the brand strategy and execution for IBSRELA, driving cross-functional alignment, demand generation, and ROI across HCP and consumer channels.

  • Own brand vision, cross-functional coordination, and performance metrics
  • Lead team and collaborations with Medical Affairs, Sales, and Communications

Job Description

Responsibilities

  • Brand Strategy & Leadership
  • Lead the evolution and execution of the brand vision, positioning, and market strategy for IBSRELA through annual brand planning process
  • Drive brand awareness and demand generation across all HCP and Consumer marketing strategies, tactics, and execution throughout all personal promotion and digital channels
  • Represent brand level initiatives, workstreams, and results at weekly, monthly, quarterly business review meetings
  • Partner cross-functionally with Medical Affairs, Market Access, Sales, Sales Training, Commercial Operations, and Corporate Communications to ensure strategic pull through across messaging, data generation, and commercialization efforts
  • Serve as the primary brand champion, ensuring consistency across all internal and external touchpoints
  • Oversee brand performance metrics and market insights to drive brand strategy, data-driven decisions, and optimize ROI
  • Oversee marketing budget, and ensure all marketing programs and campaigns support overall strategy, are executed effectively with a strong ROI, and are within budget
  • Manage external agency and vendor partnerships to maximize execution and manage budget appropriately
  • Team Management

Requirements

  • Bachelor’s degree, advanced degree (MBA) strongly preferred, with 10+ years of progressive marketing or brand leadership experience in biotech, pharmaceutical or specialty healthcare or equivalent experience
  • Demonstrated success leading commercial strategy for a launched or early-stage marketed product in a competitive therapeutic area
  • Strong verbal and written communication skills to address Commercial leadership and Executive audiences
  • Proven ability to manage and develop teams
  • Strong understanding of regulatory and compliance frameworks governing biopharma marketing
  • Strategic and analytical mindset with operational discipline
  • Collaborative and influential leader who thrives in a matrix environment
  • Entrepreneurial spirit with a bias for action and innovation
  • High emotional intelligence and executive presence
  • Gastroenterology experience preferred or relative disease state/market knowledge

Preferred

  • Gastroenterology experience preferred or relative disease state/market knowledge
  • Digital marketing experience a plus

Benefits

  • Ardelyx also offers a robust benefits package to employees, including a 401(k) plan with generous employer match, 12 weeks of paid parental leave, up to 12 weeks of living organ and bone marrow leave, equity incentive plans, health plans (medical, prescription drug, dental, and vision), life insurance and disability, flexible time off, annual Winter Holiday shut down, and at least 11 paid holidays.
Ardelyx, Inc. logo

Ardelyx, Inc.

4.1 Glassdoor

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) as well as early-stage pipeline candidates. The company is developing RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3

Founded in 2007
Waltham, Massachusetts, USA
467 employees (24 in marketing)
70% recommend to a friend
91% CEO approval

Traffic Signals

Monthly Visitors
11.9K
Traffic Source Mix
Search
42.3%
Direct
42.5%
Referral
5.8%
Social
8%
Paid
1.2%

Headcount Trend

Current headcount: ~470

Marketing Team

Marketing Team Size
23 (5% of company)
Median Career Experience
17 years
Median Tenure
2.3 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$557.7M
Last Raise
$20M
Post IPO Debt, 4 years ago

Funding History

  • Jun 2022
    Post IPO Debt • $20M
  • Feb 2022
    Post IPO Debt • $27.5M
  • Dec 2019
    Post IPO Equity • $125M

Recent News